Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

Cited by (1,009)

Items 801–900 of 1,009

1. Polygenic Susceptibility to Breast Cancer: Current State-of-The-Art
   Maya Ghoussaini, Paul D.P. Pharoah · 2009 · Future Oncology
2. Penetrance and Expressivity in Inherited Cancer Predisposing Syndromes
   Taeubner, Julia, Wieczorek, Dagmar, Yasin, Layal, Brozou, Triantafyllia, Borkhardt, Arndt, Kuhlen, Michaela · 2018 · Trends in Cancer
3. HBOC multi-gene panel testing: comparison of two sequencing centers
   Christopher Schroeder, Ulrike Faust, Marc Sturm, Karl Hackmann, Kathrin Grundmann, Florian Harmuth, Kristin Bosse, Martin Kehrer, Tanja Benkert, Barbara Klink et al. · 2015 · Breast Cancer Research and Treatment
4. Fertility preservation and breast cancer: a review
   María de Pedro · 2015 · ecancermedicalscience
5. Risk Reduction Behaviors and Provider Communication Following Genetic Counseling and BRCA1 Mutation Testing in an African American Kindred
   Anita Yeomans Kinney, Sara Ellis Simonsen, Bonnie Jeanne Baty, Diptasri M. Mandal, Susan L. Neuhausen, Kate Seggar, Richard Holubkov, Lindsey E. Bloor, Ken Robert Smith · 2006 · Journal of Genetic Counseling
6. Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening
   Melissa Kristen Frey, Sarah H. Kim, Rebecca Yee Bassett, Jessica Martineau, Emily Dalton, Jing‐Yi Chern, Stephanie V. Blank · 2015 · Gynecologic Oncology
7. Methylation profiles of hereditary and sporadic ovarian cancer
   Guus Martinus Bol, Karijn P.M. Suijkerbuijk, Joost Bart, Marc Vooijs, Elsken van der Wall, P. J. van Diest · 2010 · Histopathology
8. BRAT1 mutations present with a spectrum of clinical severity
   Siddharth Srivastava, Heather E. Olson, Julie S. Cohen, Cynthia Sophia Gubbels, Sharyn A. Lincoln, Brigette Tippin Davis, Layla Shahmirzadi, Siddharth S. Gupta, Jonathan D. Picker, Timothy W. Yu et al. · 2016 · American Journal of Medical Genetics Part A
9. Inherited mutations in DNA repair genes and cancer risk
   Nuria Romero-Laorden, Elena Castro · 2017 · Current Problems in Cancer
10. Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients
    Diana Torres, J Lorenzo Bermejo, Muhammad Usman Rashid, Ignacio Briceño, Fabián Gil, Ángela Patricia Beltrán López, Víctor Morales Ariza, Ute Hamann · 2017 · Scientific Reports
11. Surgically Induced Menopause—A Practical Review of Literature
    Cristina Anamaria Secoşan, Oana Balint, Laurențiu Pirtea, Dorin Grigoraş, Ligia Bălulescu, Răzvan Ştefan Ilina · 2019 · Medicina
12. Update on Genetic Testing in Gynecologic Cancer
    Susan M. Domchek, Mark E. Robson · 2019 · Journal of Clinical Oncology
13. Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers
    Faiza Gaba, Ranjit Manchanda · 2020 · Best Practice & Research Clinical Obstetrics & Gynaecology
14. The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Amanda B. Spurdle, Antonis C. Antoniou, David L. Duffy, Nirmala Pandeya, Livia Kelemen, Xiaoqing Chen, Susan Peock, Margaret R. Cook, Paula L. Smith, David M. Purdie et al. · 2004 · Breast Cancer Research
15. Enhanced Counseling for Women Undergoing BRCA1/2 Testing: Impact on Subsequent Decision Making About Risk Reduction Behaviors
    Suzanne M. Miller, Pagona Roussi, Mary B. Daly, Joanne S. Buzaglo, Kerry Anne Sherman, Andrew K. Godwin, Andrew M. Balshem, Margaret E. Atchison · 2005 · Health Education & Behavior
16. Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines
    Kevin Ha, Emilie Lalonde, Lili Li, Luca Cavallone, Rachael Natrajan, Maryou B. K. Lambros, Costas Mitsopoulos, Jarle Hakas, Iwanka Kozarewa, Kerry Fenwick et al. · 2011 · BMC Medical Genomics
17. Hereditary breast cancer syndromes and genetic testing
    Thereasa A. Rich, Ashley Woodson, Jennifer Keating Litton, Banu K Arun · 2014 · Journal of Surgical Oncology
18. Detection of Breast Cancer 1 (BRCA1) Gene Using an Electrochemical DNA Biosensor Based on Immobilized ZnO Nanowires
    Nur Azimah Mansor, Zainiharyati Mohd Zain, Hairul Hisham Hamzah, Mohd Shihabuddin Ahmad Noorden, Siti Safura Jaapar, Valerio Beni, Zafar Hussain Ibupoto · 2014 · Open Journal of Applied Biosensor
19. Disclosure of positive BRCA1/2-mutation status in young couples: The journey from uncertainty to bonding through partner support.
    Lindsey M. Hoskins, Kevin M. Roy, June A. Peters, Jennifer T. Loud, Mark H. Greene · 2008 · Families Systems & Health
20. Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics
    Claire Julian‐Reynier, Anne‐Déborah Bouhnik, Emanuelle Mouret-Fourme, Marion Gauthier‐Villars, Pascaline Berthet, Christine Lasset, Jean‐Pierre Fricker, Olivier Caron, Paul Gesta, Élisabeth Luporsi et al. · 2010 · Genetics in Medicine
21. Reduced penetrance in human inherited disease
    Rabah Mohamed Shawky · 2014 · Egyptian Journal of Medical Human Genetics
22. The risk of breast cancer in women with a BRCA1 mutation from North America and Poland
    Jan Lubiński, Tomasz Huzarski, Tomasz Byrski, Henry T. Lynch, Cezary Cybulski, Parviz Ghadirian, Małgorzata Stawicka, William David Foulkes, Ewa Kilar, Charmaine Kim‐Sing et al. · 2011 · International Journal of Cancer
23. Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families
    Zhi Ling Teo, Daniel Jonathan Park, Elena Provenzano, Catherine Chatfield, Fabrice Odefrey, Tú Nguyen‐Dumont, kConFab, James G. Dowty, John Llewelyn Hopper, Ingrid Winship et al. · 2013 · Breast Cancer Research
24. A Simulation Model to Predict the Impact of Prophylactic Surgery and Screening on the Life Expectancy of BRCA1 and BRCA2 Mutation Carriers
    Bronislava M. Sigal, Diego F. Muñoz, Allison W. Kurian, Sylvia K. Plevritis · 2012 · Cancer Epidemiology Biomarkers & Prevention
25. A Review of Whole-Exome Sequencing Efforts Toward Hereditary Breast Cancer Susceptibility Gene Discovery
    Madison R. Chandler, Erin P. Bilgili, Nancy D. Merner · 2016 · Human Mutation
26. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers
    Shoko Vos, Cathy Beatrice Moelans, P. J. van Diest · 2017 · Breast Cancer Research
27. Breast Cancer: Exploring the Facts and Holistic Needs during and beyond Treatment
    Zhi Ng, Mei Xuan Ong, Tamilarasi Jegadeesan, Shuo Deng, Celestial T. Yap · 2017 · Healthcare
28. Smoking and physical inactivity increase cancer prevalence in BRCA-1 and BRCA-2 mutation carriers: results from a retrospective observational analysis
    Sabine Grill, Maryam Yahiaoui‐Doktor, Ricarda Dukatz, Jacqueline Lammert, Mirjam Ullrich, Christoph Engel, Katharina Pfeifer, Maryam Basrai, Michael Siniatchkin, Thorsten Schmidt et al. · 2017 · Archives of Gynecology and Obstetrics
29. Targeting BRCA Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?
    Emanuel Nicolas, François Bertucci, Renaud Sabatier, Anthony Gonçalvès · 2018 · Cancers
30. The role of genomics in global cancer prevention
    Ophira Ginsburg, Patrícia Ashton‐Prolla, Anna Cantor, Daniela Mariosa, Paul Brennan · 2020 · Nature Reviews Clinical Oncology
31. Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis
    Matthew Gerard Davey, Ciara M. Davey, Éanna J. Ryan, Aoïfe Lowery, Michael Joseph Kerin · 2021 · The Breast
32. A complex of BRCA2 and PP2A-B56 is required for DNA repair by homologous recombination
    Sara M. Ambjørn, Julien P. Duxin, Emil Peter Thrane Hertz, Isha Nasa, Joana Duro, Thomas Kruse, Blanca Lopez Mendez, Beata Rymarczyk, Lauren E. Cressey, Thomas van Overeem Hansen et al. · 2021 · Nature Communications
33. Hereditary ovarian cancer in Ashkenazi Jews
    Luis Robles-d�az, Deborah J. Goldfrank, Noah D. Kauff, Mark E. Robson, Kenneth Offit · 2004 · Familial Cancer
34. DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers
    Joanne Kotsopoulos, Z Chen, Katherine A. Vallis, Aletta Poll, Peter Ainsworth, Steven Alexander Narod · 2007 · British Journal of Cancer
35. Understanding Susceptibility to Breast Cancer: From Risk Factors to Prevention Strategies
    Natalia García‐Sancha, Roberto Corchado‐Cobos, Jesús Pérez‐Losada · 2025 · International Journal of Molecular Sciences
36. Fanconi anemia and solid malignancies in childhood: A national retrospective study
    Aurore Malric, Anne Sophie Defachelles, Thierry M Leblanc, Brigitte Lescoeur, Brigitte Lacour, Michel M. Peuchmaur, Claude‐Alain Maurage, Gaëlle Pierron, Delphine Guillemot, Catherine Dubois d’Enghien et al. · 2014 · Pediatric Blood & Cancer
37. Pattern response of dendritic cells in the tumor microenvironment and breast cancer
    Alessandra da Cunha · 2014 · World Journal of Clinical Oncology
38. Genetic Tests to Identify Risk for Breast Cancer
    Julie Ann Lynch, Vickie L. Venne, Brygida Berse · 2015 · Seminars in Oncology Nursing
39. The Changing Face of Mastectomy (from Mutilation to Aid to Breast Reconstruction)
    Stefano Zurrida, Fabio Domenico Bassi, Paolo Arnone, Stefano Martella, Andrés del Castillo, Rafael Ribeiro Martini, M. Eugenia Semenkiw, Pietro Caldarella · 2011 · International Journal of Surgical Oncology
40. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study
    Camille Cluze, Patricia Delafosse, Arnaud Seigneurin, Marc Colonna · 2009 · European Journal of Cancer Prevention
41. Breast Cancer Screening in<i>BRCA1</i>Mutation Carriers: Effectiveness of MR Imaging—Markov Monte Carlo Decision Analysis
    Lee, Janie M., Kopans, Daniel B., McMahon, Pamela M., Halpern, Elkan F., Ryan, Paula D., Weinstein, Milton C., Gazelle, G. Scott · 2008 · Radiology
42. Polymorphisms inRAD51, XRCC2, andXRCC3Are Not Related to Breast Cancer Risk
    Jennifer D. Brooks, Roy E. Shore, Anne Zeleniuch‐Jacquotte, Diane Currie, Yelena Afanasyeva, Karen L. Koenig, Alan A. Arslan, Paolo G. Toniolo, Isaac I. Wirgin · 2008 · Cancer Epidemiology Biomarkers & Prevention
43. Cancer Risk Assessment Using Genetic Panel Testing: Considerations for Clinical Application
    Susan C. Hiraki, Erica S. Rinella, Freya Ruth Schnabel, Ruth Oratz, Harry Ostrer M. D · 2014 · Journal of Genetic Counseling
44. More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling
    Aisha S. Sie, Wendy A.G. van Zelst–Stams, Liesbeth Spruijt, Arjen R. Mensenkamp, Marjolijn J. L. Ligtenberg, Han G. Brunner, Judith B. Prins, Nicoline Hoogerbrugge · 2013 · Familial Cancer
45. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
    David G. Cox, Jacques Simard, Daniel Sinnett, Yosr Hamdi, Penny Soucy, Manon Ouimet, Laure Barjhoux, Carole Verny-Pierre, Lesley McGuffog, Sue C. Healey et al. · 2011 · Human Molecular Genetics
46. Changes in the Mouse Estrus Cycle in Response to Brca1 Inactivation Suggest a Potential Link between Risk Factors for Familial and Sporadic Ovarian Cancer
    Hao Hong, Hai-Yun Yen, Amy D. Brockmeyer, Ying Liu, Rajas Chodankar, Malcolm C. Pike, Frank Z. Stanczyk, Robert E. Maxson, Louis Dubeau · 2009 · Cancer Research
47. The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
    Marie Eliade, Jérémy Skrzypski, Amandine Baurand, Caroline Jacquot, Geoffrey Bertolone, Catherine Loustalot, Charles Coutant, France Guy, P. Fumoleau, Yannis Duffourd et al. · 2016 · Oncotarget
48. Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability
    Jaime L. Stafford, Gregory E. Dyson, Nancy K. Levin, Sophia R. Chaudhry, Rita Rosati, Hasini A. Kalpage, Courtney Wernette, Nancie Petrucelli, Michael Steven Simon, Michael A. Tainsky · 2017 · PLoS ONE
49. Global Disparities in Breast Cancer Genetics Testing, Counselling and Management
    Cheng Har Yip, D. Gareth Evans, Gaurav Agarwal, Ines Buccimazza, Ava Kwong, R. Morant, Ipshita Prakash, Chin-Vern Song, Nur Aishah Mohd Taib, Christoph Tausch et al. · 2019 · World Journal of Surgery
50. Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA
    Zhanzhan Xu, Xiaoman Li, Hanxiao Li, Chen Nie, Wanchang Liu, Shiwei Li, Zelin Liu, Weibin Wang, Jiadong Wang · 2020 · Oncogene
51. Development and Evaluation of a Decision Aid for BRCA Carriers with Breast Cancer
    Julie O. Culver, Deborah J. MacDonald, Andrea A. Thornton, Sharon R. Sand, MARCIA M. GRANT, Deborah J. Bowen, HARRY B. BURKE, Nellie Garcia, Kelly A. Metcalfe, Jeffrey N. Weitzel · 2011 · Journal of Genetic Counseling
52. Estimating penetrance from family data using a retrospective likelihood when ascertainment depends on genotype and age of onset
    Jérôme Carayol, Catherine Bonaïti‐Pellié · 2004 · Genetic Epidemiology
53. Epidemiology of breast cancer among BRCA mutation carriers: an overview
    André Nkondjock, Parviz Ghadirian · 2003 · Cancer Letters
54. Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis
    Metcalfe, Kelly, Huzarski, Tomasz, Gronwald, Jacek, Kotsopoulos, Joanne, Kim, Raymond, Moller, Pal, Pal, Tuya, Aeilts, Amber, Eisen, Andrea, Karlan, Beth et al. · 2024 · British Journal of Cancer
55. Epidemiology, Genetic Etiology, and Intervention of Premature Ovarian Insufficiency
    Ting Guo, Hongyuan Liu, Bingying Xu, Yu Qi, Keyan Xu, Xinyi Wu, Xinmiao He, Yingying Qin, Zi‐Jiang Chen · 2025 · Endocrine Reviews
56. Short term psychological distress in patients actively approached for genetic counselling after diagnosis of breast cancer
    Kathryn J. Schlich‐Bakker, Carla C. Wárlám-Rodenhuis, Jeanne van Echtelt, Jan van den Bout, Margreet G.E.M. Ausems, Herman F. J. ten Kroode · 2006 · European Journal of Cancer
57. PALB2 and breast cancer: ready for clinical translation!
    Melissa C. Southey, Teo, Ingrid Winship · 2013 · The Application of Clinical Genetics
58. Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations: Findings From the Breast Cancer Family Registry
    Allison W. Kurian, Gail D. Gong, Esther M. John, David A. Johnston, Anna Felberg, Dee W. West, Alexander Miron, Irene Louise Andrulis, John Llewelyn Hopper, Julia A. Knight et al. · 2011 · Journal of Clinical Oncology
59. Targeted therapy in breast cancer: what’s new?
    Fang Li, Zeinab Barekati, Bingnan Zhang, Z Liu, XY Zhong · 2011 · Swiss Medical Weekly
60. Genetic causes of cancer predisposition in children and adolescents.
    Federica Saletta, Luciano Dalla Pozza, Jennifer Anne Byrne · 2015 · PubMed Central
61. Tissue engineering and regenerative medicine strategies for the female breast
    Claudio Conci, Lorenzo Bennati, Chiara Bregoli, Federica Buccino, Francesca Danielli, Michela Gallan, Ereza Gjini, Manuela Teresa Raimondi · 2019 · Journal of Tissue Engineering and Regenerative Medicine
62. The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database
    Maiko Okano, Tadashi Nomizu, Kazunoshin Tachibana, Miki NAGATSUKA, Masami Matsuzaki, Naoto Katagata, Toru Ohtake, Shiro Yokoyama, Masami Arai, Seigo Nakamura · 2020 · Journal of Human Genetics
63. Genetic Risk Assessments in Individuals at High Risk for Inherited Breast Cancer in the Breast Oncology Care Setting
    Tuya Pal, Susan Thomas Vadaparampil · 2012 · Cancer Control
64. Why have ovarian cancer mortality rates declined? Part III. Prospects for the future
    Victoria Sopik, Barry P. Rosen, Vasily Giannakeas, Steven Alexander Narod · 2015 · Gynecologic Oncology
65. Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years
    Breast Cancer Family Registry, Ontario Cancer Genetics Network (Canada) · 2007 · Breast Cancer Research and Treatment
66. Variants of Uncertain Clinical Significance as a Result of BRCA1/2 Testing: Impact of an Ambiguous Breast Cancer Risk Message
    Sandra Van Dijk, Christie J. van Asperen, Catharina E. Jacobi, Geraldine R. Vink, Aad Tibben, Martijn H. Breuning, Wilma Otten · 2004 · Genetic Testing
67. MRI in the Early Detection of Breast Cancer in Women with High Genetic Risk
    Giovanna Trecate, Daniele Vergnaghi, Siranuosh Manoukian, Silvana Bergonzi, Gianfranco Paride Scaperrotta, Monica Marchesini, Claudio Ferranti, Bernard Peissel, Gianbattista Spatti, Silvia Böhm et al. · 2006 · Tumori Journal
68. A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not?
    Shoko Vos, P. J. van Diest, Cathy Beatrice Moelans · 2018 · Critical Reviews in Oncology/Hematology
69. Update of penetrance estimates in Birt-Hogg-Dubé syndrome
    Fiona Bruinsma, James G. Dowty, Aung Ko Win, Laura C Goddard, Prachi Agrawal, Domenico Attinà, Nabil K. Bissada, Monica De Luise, Daniel Brian Eisen, Mitsuko Furuya et al. · 2023 · Journal of Medical Genetics
70. Evaluation of Association Methods for Analysing Modifiers of Disease Risk in Carriers of High‐Risk Mutations
    Daniel R. Barnes, Andrew Lee, EMBRACE Investigators, kConFab Investigators, Douglas F. Easton, Antonis C. Antoniou · 2012 · Genetic Epidemiology
71. Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing
    Courtney Lynam Scherr, Noralane M. Lindor, Teri L. Malo, Fergus J. Couch, Susan Thomas Vadaparampil · 2015 · Clinical Genetics
72. Keeping it simple: Genetics referrals for all invasive serous ovarian cancers
    Rochelle Demsky, Jeanna Marie McCuaig, Manjula D. Maganti, K.J. Murphy, Barry P. Rosen, Susan Randall Armel · 2013 · Gynecologic Oncology
73. Association of the VariantsCASP8D302H andCASP10V410I with Breast and Ovarian Cancer Risk inBRCA1andBRCA2Mutation Carriers
    Christoph Engel, Beatrix Versmold, Barbara Wappenschmidt, Jacques Simard, Douglas F. Easton, Susan Peock, Margaret Cook, Clare Oliver, Debra Frost, Rebecca Mayes et al. · 2010 · Cancer Epidemiology Biomarkers & Prevention
74. Screening for Ovarian Cancer
    Janiel M. Cragun · 2011 · Cancer Control
75. Out-RANKing BRCA1 in Mutation Carriers
    Emma Nolan, Geoffrey John Lindeman, Jane E. Visvader · 2017 · Cancer Research
76. Current and future role of genetic screening in gynecologic malignancies
    Kari Lassen Ring, Christine Ann Garcia, Martha H. Thomas, Susan C. Modesitt · 2017 · American Journal of Obstetrics and Gynecology
77. Inflammatory signaling in genomically instable cancers
    Francien Talens, Marcel A.T.M. van Vugt · 2019 · Cell Cycle
78. Outcome of a structured surveillance programme in women with a familial predisposition for breast cancer
    Rita Katharina Schmutzler, Kerstin Rhiem, Petra Breuer, Eva Wardelmann, Martin Lehnert, Silke Coburger, Barbara Wappenschmidt · 2006 · European Journal of Cancer Prevention
79. The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited
    Nicoline Hoogerbrugge, Yvonne J. L. Kamm, Peter Bult, Karin M. Landsbergen, Ernie M.H.F. Bongers, Han G. Brunner, Han J. Bonenkamp, Joanne A. de Hullu, M J Ligtenberg, Carla Boetes · 2007 · Annals of Oncology
80. Breast cancer in young women: Pathologic features and molecular phenotype
    Laura Sabiani, Gilles F. Houvenaeghel, Mellie Heinemann, Fabien Reyal, Jean‐Marc Classe, Monique Cohen, J.-R. Garbay, Sylvia Giard, H. Charitansky, Nicolas Chopin et al. · 2016 · The Breast
81. Preimplantation genetic diagnosis for BRCA1 exon 13 duplication mutation using linked polymorphic markers resulting in a live birth
    Melinda Jane Jasper, Jan E. Liebelt, Nicole D. Hussey · 2008 · Prenatal Diagnosis
82. Ashkenazi Jews and Breast Cancer: The Consequences of Linking Ethnic Identity to Genetic Disease
    Sherry I. Brandt-Rauf, Victoria H. Raveis, Nathan F. Drummond, Jill Conte, Sheila M. Rothman · 2006 · American Journal of Public Health
83. Genomic characterization of lymphomas in patients with inborn errors of immunity
    Xiaofei Ye, Paul J. Maglione, Claudia Wehr, Xiaobo Li, Yating Wang, Hassan Abolhassani, Elena V. Deripapa, Dongbing Liu, Stephan Borte, Likun Du et al. · 2022 · Blood Advances
84. Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review
    Serena Bertozzi, Ambrogio Pietro Londero, Anjeza Xholli, Guglielmo Azioni, Roberta Di Vora, Michele Paudice, Ines Bucimazza, Carla Cedolini, Angelo Cagnacci · 2023 · Journal of Clinical Medicine
85. Structural basis for stabilisation of the RAD51 nucleoprotein filament by BRCA2
    Robert E Appleby, Luay I. Joudeh, Katie Cobbett, Luca Pellegrini · 2023 · Nature Communications
86. S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours
    Uwe A. G. Wagner, Philipp Harter, Felix Hilpert, Sven� Mahner, Alexander Reuß, Andreas du Bois, Edgar Petru, Werner Meier, Petra Angelika Ortner, K. König et al. · 2013 · Geburtshilfe und Frauenheilkunde
87. Hereditary breast cancer: beyond BRCA genetic analysis; PALB2 emerges
    Νικολέτα Πουμπουρίδου, Christos Κroupis · 2012 · Clinical Chemistry and Laboratory Medicine (CCLM)
88. HO-3867, a STAT3 inhibitor induces apoptosis by inactivation of STAT3 activity in BRCA1-mutated ovarian cancer cells
    Brent J. Tierney, Georgia Anne-Lee McCann, David E. Cohn, E. Eisenhauer, Meryl Sudhakar, Periannan Kuppusamy, Kálmán Hideg, Karuppaiyah Selvendiran · 2012 · Cancer Biology & Therapy
89. BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models
    Carlo Capalbo, Enrico Ricevuto, Annarita Vestri, Elisabetta Ristori, Tina Sidoni, O. Buffone, Bárbara Adamo, Enrico Cortesi, Paolo Marchetti, Giovanni Scambia et al. · 2006 · Annals of Oncology
90. Surgical Decision Making in the BRCA-Positive Population: Institutional Experience and Comparison with Recent Literature
    Teresa S. Flippo-Morton, Kendall K. Walsh, Karinn Marie Chambers, Lisa Amacker-North, Brook White, Terry Sarantou, Danielle M. Boselli, Richard L. White · 2015 · The Breast Journal
91. Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome
    Tomoko Kaneyasu, Seiichi Mori, Hideko Yamauchi, Shozo Ohsumi, Shinji Ohno, Daisuke Aoki, Shinichi Baba, Junko Kawano, Yoshio Miki, Naomichi Matsumoto et al. · 2020 · npj Breast Cancer
92. Psychological distress in women at risk for hereditary breast cancer: the role of family communication and perceived social support
    Mariska den Heijer, Caroline Seynaeve, Kathleen Vanheusden, Hugo Joseph Duivenvoorden, Carina C. M. Bartels, Marian B. E. Menke‐Pluymers, Aad Tibben · 2010 · Psycho-Oncology
93. Functional, structural, and genetic evaluation of 20CDKN2Agerm line mutations identified in melanoma-prone families or patients
    Caroline Kannengiesser, Sharon Brookes, Anna Gutierrez del Arroyo, Danielle Pham, Johny Bombled, Michel Barrois, Olivier Mauffret, Marie-Fran��oise Avril M, Agn��s Chompret, Gilbert Lenoir et al. · 2009 · Human Mutation
94. First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case report
    Carla Barbara Ripamonti, Mara Colombo, Patrizia Mondini, Siranoush Manoukian, Bernard Peissel, Loris Bernard, Paolo Radice, Maria Luisa Carcangiu · 2013 · BMC Cancer
95. Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2mutation status
    Niklas Loman, Anna Bladström, Oskar T. Johannsson, Åke Borg, Hakan Lars Olsson · 2003 · Breast Cancer Research
96. Satisfaction and Impact on Quality of Life of Clinical and Instrumental Surveillance and Prophylactic Surgery in BRCA-mutation Carriers
    D'Alonzo, Marta, Piva, Eleonora, Pecchio, Silvia, Liberale, Viola, Modaffari, Paola, Ponzone, Riccardo, Biglia, Nicoletta · 2018 · Clinical Breast Cancer
97. Electrochemical biosensors for analysis of DNA point mutations in cancer research
    Katerina Ondraskova, Ravery Sebuyoya, Ludmila Moráňová, Jitka Holčáková, Petr Voňka, Roman Hrstka, Martin Bartošík · 2022 · Analytical and Bioanalytical Chemistry
98. Mammary Glands of Women, Female Dogs and Female Rats: Similarities and Differences to Be Considered in Breast Cancer Research
    Tiago Ferreira, Adelina Gama, Fernanda Seixas, Ana I. Faustino‐Rocha, Carlos Lopes, Vítor M. Gaspar, João Filipe Mano, Rui Medeiros, Paula A. Oliveira · 2023 · Veterinary Sciences
99. Polygenic scores in cancer
    Xin Yang, Siddhartha Kar, Antonis C. Antoniou, Paul D.P. Pharoah · 2023 · Nature reviews. Cancer
100. BRCA1/2 Mutations and Breast/Ovarian Cancer Risk: A New Insights Review
     Parvin Pourmasoumi, Ali Moradi, Mohammad Bayat · 2024 · Reproductive Sciences